Review: ‘No concern about excess CVD risks associated with calcium supplements’

By Asia Sherman

- Last updated on GMT

© skhoward / Getty Images
© skhoward / Getty Images

Related tags Calcium Vitamin d Cardiovascular disease Bone health

A recent review published in the journal Current Developments in Nutrition dispels concerns that have swirled around calcium supplementation and the increased risk of cardiovascular disease (CVD).

“For people with low-bone density and low absolute risks of CVD, the present report demonstrates no concern about excess CVD risks associated with calcium supplements,” the team of international researchers wrote on behalf of the Calcium Supplements Treatment Trialists’ Collaboration.

The researchers evaluated 11 trials, including seven comparisons of calcium to control (n​ = 8,634) and six comparisons of calcium plus vitamin D to control (n​ = 46,804).

Considering the hazards

Calcium supplements, particularly when accompanied by Vitamin D, have long been used to treat or prevent bone disease like osteoporosis, which has been described as a silent killer. In the last ten years, however, studies have emerged questioning the safety of calcium supplementation, linking it to coronary artery calcification and increased cardiovascular risk.

2012 study led by Zurich University’s Institute of Social and Preventative Medicine​, for example, cautioned against calcium supplementation, suggesting that it could double the risk of heart attack incidence. More recently​, a large retrospective cohort study concluded that “the cumulative incidence and hazard ratio for acute myocardial infarction, ischemic stroke and death events were higher in the calcium supplementation group than in the control group in a Korean population after adjusting for confounding variables.”

This latest meta-analysis, however, adds to the overall body of science supporting the potential safety of calcium supplements, previously buttressed by a Harvard Medical School study​ and findings published in Osteoporosis International​, among others, showing no effect on coronary artery calcification. 

No excess risk in people with low absolute risks

For this review, the research team conducted a systematic search of randomized, placebo-controlled calcium supplement trials reported in the PubMed, Medline and Embase databases, as well as the Cochrane Central Register of Controlled Trials. This was supplemented by a search of reference lists of individual trials, review articles or previous meta-analyses of calcium and risk of coronary heart disease, stroke or all-cause mortality. 

“This meta-analysis demonstrated that calcium supplements were not associated with any significant hazard for coronary heart disease, stroke or all-cause mortality and excluded excess risks above 0.3%–0.5% per year for coronary heart disease or stroke,” the researchers stated. 

Likewise, the six trials evaluating the combined calcium and vitamin D treatment showed no significant associations between supplementation and any type of excess risk. 

The study called for further large trials "to assess the efficacy and safety of combined supplementation with calcium and vitamin D for the prevention of osteoporotic fracture in older people at high risk of CVD.”

Confidence in the safety of calcium supplements

Commenting independently on the findings, Andrea Wong, PhD, senior vice president of scientific and regulatory affairs at the Council for Responsible Nutrition (CRN) told NutraIngredients-USA: “This meta-analysis is the latest research to reinforce the safety of calcium supplementation. Since many Americans don’t get enough calcium in their diet, supplementation can play an important role in meeting nutrient needs. This research, along with several other studies, should provide confidence in the safety of calcium supplements for heart health."

In addition to the health benefits, Dr. Wong refers to the CRN Health Care Cost Savings study​, which identified an average net savings of $17 billion per year in health care costs associated with osteoporotic fracture if the entire target population of adults over the age of 50 were to supplement daily with calcium and vitamin D.

Source: Current Developments in Nutrition
“Calcium Supplements and Risk of CVD: A Meta-Analysis of Randomized Trials”
Authors: Xiquian Huo et al.

Related news

Related products

show more

Golden Omega® Sustainability Strategy

Golden Omega® Sustainability Strategy

Content provided by LEHVOSS Nutrition | 11-Sep-2023 | Data Sheet

Commitment to sustainability at Golden Omega® is ever growing as they continue to put objectives in place to secure a better environment for the future....

Omega-3:Nutrition and Application Insight

Omega-3:Nutrition and Application Insight

Content provided by Cabio Biotech (Wuhan) Co., Ltd | 31-Jul-2023 | White Paper

Omega-3 long-chain polyunsaturated fatty acids (PUFAs) have numerous positive health benefits and are among the most extensively studied micronutrients....

LIPOFER™: a bioavailable and stable source of iron

LIPOFER™: a bioavailable and stable source of iron

Content provided by Lipofoods, a Lubrizol Company | 26-Apr-2023 | White Paper

Maintaining adequate iron levels is critical to maintaining a healthy body, with deficiencies being the cause of several health issues including anemia...

Related suppliers

Follow us


View more